934568-20-4 Usage
General Description
1-Methyl-7-azaindole-5-carboxylic acid is a chemical compound with a molecular formula C10H8N2O2. It is a derivative of indole and contains a carboxylic acid group. 1-Methyl-7-azaindole-5-carboxylic acid is commonly used in the pharmaceutical industry as a starting material for the synthesis of various bioactive molecules. It has shown potential as an antimicrobial agent and has also been studied for its potential use in the treatment of cancer and other diseases. Additionally, 1-Methyl-7-azaindole-5-carboxylic acid has been investigated for its role in the development of new materials and is of interest in the field of organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 934568-20-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,4,5,6 and 8 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 934568-20:
(8*9)+(7*3)+(6*4)+(5*5)+(4*6)+(3*8)+(2*2)+(1*0)=194
194 % 10 = 4
So 934568-20-4 is a valid CAS Registry Number.
InChI:InChI=1S/C9H8N2O2/c1-11-3-2-6-4-7(9(12)13)5-10-8(6)11/h2-5H,1H3,(H,12,13)
934568-20-4Relevant articles and documents
PYRAZOLOPYRIMIDINES AS INHIBITORS OF GLUCOCORTICOID RECEPTOR TRANSLOCATION
-
, (2016/08/23)
Provided herein are compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of Glucocorticoid Receptor (GR) translocation. Furthermore, the subject compounds and compositions are useful for the treatment of diseases involved in the hypothalamic-pituitary-adrenal (HPA) axis.
AMIDE COMPOUNDS, COMPOSITIONS AND APPLICATIONS THEREOF
-
, (2013/04/10)
The present disclosure relates to substituted amide compounds that are inhibitors of Fatty Acid Amide Hydrolase (FAAH), their stereoisomers, tautomers, prodrugs, polymorphs, solvates, pharmaceutically acceptable salts, and pharmaceutical compositions cont
NOVEL SUBSTITUTED AZABENZOXAZOLES
-
, (2010/01/12)
The present invention relates to novel amyloid binding compounds and methods for measuring effects of the compounds, by measuring changes of amyloid plaque level in living patients. More specifically, the present invention relates to a method of using the